J&J Under CEO Gorsky Will Remain Diverse But Be More Selective
This article was originally published in The Pink Sheet Daily
Executive Summary
New CEO Alex Gorsky outlines his vision for the healthcare giant in his first quarterly sales and earnings presentation to investors. Short-term priorities include restoring OTC drug supply and building pharmaceutical sales momentum.